Since April 2020, the ACT-Accelerator partnership, launched by WHO and partners, has supported the fastest, most coordinated, and successful global effort in history to develop tools to fight a disease. With significant advances in research and development by academia, private sector and government initiatives, the ACT-Accelerator is on the cusp of securing a way to end the acute phase of the pandemic by deploying the tests, treatments and vaccines the world needs.
Given the ongoing pandemic and need for more equitable access to COVID-19 tools, stakeholders have proposed a strategic review of ACT Accelerator to inform decision-making on enhancing its current functioning and about its potential role beyond the 1st quarter of 2022.
The strategic review will consider ACT Accelerator achievements, best practices, challenges and gaps as a basis for recommendations to enhance its future work.
The Request for Proposals published on the United Nations Global Marketplace website closed on 15 July and the proposals are under a selection process.
The ACT Accelerator initial needs were of US$ 38.1 billion to complete its work of delivering tests, treatments and vaccines around the world to treat...
The Facilitation Council provides high-level political leadership and enabling advice on global advocacy and resource mobilization to facilitate the work of the COVID-19 Tools Accelerator (ACT-A), its global collaborative framework, and its partnerships to ensure the realization of the ACT-A vision: the rapid development, scale-up and equitable distribution of COVID-19 vaccines, therapeutics and diagnostics, underpinned by the strengthening of health systems.
Formally launched on 10 September 2020, the Council is currently co-chaired by Norway and South Africa.
Statement on the eighth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic
WHO supporting South African consortium to establish first COVID mRNA vaccine technology transfer hub